🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective is to evaluate the efficacy of IV administration of the ...
Status
Recruiting
Location
CHU de Besançon
Start Date
2022-03-02
Trial ID
NCT04667078
Treatments Being Tested
The MONET BRIDGE study is designed to assess the use of cangrelor as a plat...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03862651
Treatments Being Tested
Platelets and thrombus formation play a key role in the pathogenesis of acu...
Status
Completed
Location
Attikon University Hospital
Start Date
2017-07-28
Trial ID
NCT02943369
Treatments Being Tested
There are two separate objectives in this study: 1. To demonstrate the pha...
Status
Completed
Location
Fletcher Allen Health Care
Start Date
2013-12-02
Trial ID
NCT01979445
Treatments Being Tested
The SURVIVE trial aims to test whether using an anti-thrombotic regimen inv...
Status
Recruiting
Location
IRCCS San Raffaele Hospital
Start Date
2024-04-01
Trial ID
NCT06792643
Treatments Being Tested
The objective of this study is to evaluate if aggressive antiplatelet thera...
Status
Completed
Location
Mount Sinai Medical Center
Start Date
2007-04
Trial ID
NCT01103440
Treatments Being Tested
This study aims to evaluate the impact on myocardial reperfusion and residu...
Status
Completed
Location
CAEN University Hospital
Start Date
2021-06-08
Trial ID
NCT04927949
Treatments Being Tested
The study is designed to compare the efficacy and safety profile of cangrel...
Status
Completed
Location
Anderson Area Medical Center
Start Date
2010-09
Trial ID
NCT01156571
Primary percutaneous coronary intervention (PCI) is the main reperfusion th...
Status
Completed
Location
University of Ferrara
Start Date
2017-07-04
Trial ID
NCT02978040
Cangrelor is a fast and directly acting platelet aggregation inhibitor. It ...
Status
Completed
Location
R.S. Hermanides
Start Date
2019-12-17
Trial ID
NCT04138641
Treatments Being Tested